Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis

Published:2000-11 Issue:48 Volume:19 Page:5477-5486
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Hinz Sebastian,Trauzold Anna,Boenicke Lars,Sandberg Christiane,Beckmann Sandra,Bayer Ernst,Walczak Henning,Kalthoff Holger,Ungefroren Hendrik

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1203936.pdf

Reference57 articles.

1. Ackermann EJ, Taylor JK, Narayana R and Bennett CF. . 1999 J. Biol. Chem. 274: 11245–11252.

2. Alam MK, Davison S, Siddiqui N, Norton JD and Murphy JJ. . 1997 Eur. J. Immunol. 27: 3485–3491.

3. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH. . 1999 J. Clin. Invest. 104: 155–162.

4. Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, Blenis J and Tschopp J. . 2000 Nat. Cell Biol. 2: 241–243.

5. Boise LH and Thompson CB. . 1997 Proc. Natl. Acad. Sci. USA 94: 3759–3764.

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRIAL-based combination therapies in cancers;International Immunopharmacology;2024-09

2. Targeting apoptotic pathways for cancer therapy;Journal of Clinical Investigation;2024-07-15

3. Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells;Cancer Drug Resistance;2024-04-09

4. TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling;Cells;2024-03-16

5. Cellular stress management by caspases;Current Opinion in Cell Biology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3